Wall Street doesn’t cover penny stocks, let alone companies that are ripe for acquisitions, which can give sharp retail investors a real edge… **especially now that AI makes institutional quality research....here's YOUR CHANCE.**
The quick summary:
1. **Three FDA decisions** suddenly reshaped the regulatory landscape in favor of a tiny $50M penny stock,
2. The company announced it is beginning to shop its strategic assets to Big Tobacco
3. Management believes the strategic assets **could be worth 30 times the entire company’s current valuation**.
And Wall Street barely noticed…but some retail investors see it.
Big Tobacco controlled nicotine *for decades*. Then China captured the flavored-vape market, and Big Tobacco has been fighting to reclaim it….**LEGALLY ever since.**
The tobacco giants can build or buy almost anything.
But they **cannot go back in time** and recreate what CHUC filed with the FDA in 2020 and 2022, and Big Tobacco cannot replicate the game-changing product CHUC is set to launch.
And… most people don’t know this, but one Big Tobacco player is ALREADY working with CHUC
So Big Tobacco buying CHUC outright certainly is not an outrageous idea.
But here’s a better idea...
**Instead of listening to me**, here’s your chance to run institutional-grade AI research on a penny stock that Wall Street is completely ignoring.
I’m posting the company’s Sept. 9 press release, “***Charlie's Holdings (OTCQB: CHUC) Issues Letter to Shareholders*****” in the FIRST COMMENT.**
**Suggestion.** Highlight the text of the company’s pr, and ask ChatGPT, Claude, or Gemini what CHUC could be worth to Big Tobacco and why they may be shopping themselves **right now**.
